My ePortfolio Register   

Current and future directions of immunotherapy research

Please rate this video

Please complete at least one question.

  1. The information in this video was of interest to me Disagree Agree
  2. The information in this video is likely to improve my clinical practice or research Disagree Agree
  3. I would recommend this video to my colleagues Disagree Agree
Thanks for rating
There has been a problem, please refresh and try again.
Published: 20.12.16
Views: 855

Toh Han Chong - National Cancer Centre, Singapore

Prof Toh speaks with ecancertv at the Immuno-Oncology Hong Kong 2016 meeting about changing attitudes and understanding of immunotherapy.

He considers the future development of T cell therapy, and using aspirin for chemoprevention of colorectal cancer progression.

Prof Toh also describes the prevalence of EBV nasopharyngeal tumours in Asia, and an ongoing trial of T cell therapy to combat it.

Related videos

follow us

Founding partners

European Cancer Organisation European Institute of Oncology

Founding Charities

Foundazione Umberto Veronesi Fondazione IEO Swiss Bridge

Published by

Cancer Intelligence